Germany is battling to slash drug prices domestically, all while expecting Americans to shoulder the rising costs. This stark contrast highlights the fierce struggle over global pharmaceutical pricing and market dominance
Germany is battling to slash drug prices domestically, all while expecting Americans to shoulder the rising costs. This stark contrast highlights the fierce struggle over global pharmaceutical pricing and market dominance
Australia's trade tensions with the Trump administration escalated over affordable medicines. The U.S. criticized Australia's pharmaceutical pricing policies, arguing they undermined fair trade, while Australia defended its system aimed at ensuring low-cost access to essential drugs.
